ProteinLogic

About ProteinLogic

ProteinLogic is a company focused on developing ImmiPrint(r), a novel diagnostic technology platform that uses machine learning to detect non-obvious diagnostic patterns in soluble immune proteins in blood and other body fluids. These patterns form unique signatures for disease presence, stage, and treatment response, with a primary application in ruling out Active Tuberculosis (TB) and potential expansion to other infectious, autoimmune, and inflammatory diseases.

Products & Services

ImmiPrint(r):A diagnostic technology platform that detects diagnostic patterns in immune proteins using machine learning, with a validated application for ruling out Active Tuberculosis (TB) and potential for other diseases.

Specialties

Diagnostic Technology Machine Learning in Diagnostics Infectious Diseases (e.g., Tuberculosis) Autoimmune Diseases Inflammatory Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 1350000 MR: - FA: $1.35 million FAN: 1350000	D: 2024-01-22 FD: 2024-01-22	1 investors

Grant Latest

2024-01-22

$1.4M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Dr Adrian Woolfson

Non-Executive Director

D

Dr César Milstein

Nobel Prize winner and inventor of monoclonal antibodies

M

Mr Peter Klimt

Non-Executive Chairman

C

César Milstein

Nobel Laureate in Physiology or Medicine

A

Adrian Woolfson

Doctor

N

Nick Hales

Professor

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

ProteinLogic Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised